More than 4 years has elapsed since the World Health Organization(WHO)officially announced the coronavirus disease 2019(COVID-19)as a pandemic outbreak in March 11,2020.Despite the ongoing investigations and political ...More than 4 years has elapsed since the World Health Organization(WHO)officially announced the coronavirus disease 2019(COVID-19)as a pandemic outbreak in March 11,2020.Despite the ongoing investigations and political debates upon the origin,exacerbation,resurgence,andfinal control of COVID-19,medical and scientific consensus indicates that the now endemic COVID-19 virus is one of the worst public health crises in our lifetime.Almost every person on earth has been directly or indirectly impacted by the adverse effects of the highly contagious viral pathogen-SARS-CoV-2(severe acute respiratory syndrome coronavirus 2).Indeed,the population reach of the COVID-19 infection includes governmental response measures(e.g.,lockdowns and social distancing,mandates for masks and face coverings,vaccines,etc.)that have restricted entrenched societal routines,personal mobility,and lifestyles.Unfortunately,the host of health problems linked to this viral infection linger to this day,with selective groups of people experiencing a higher risk for untoward medical outcomes and/or elevated levels of vulnerability to the post-acute sequelae of COVID-19(i.e.long-COVID).For example,a 2021 study by Logue et al.provided initial evidence that 10%–30%of individuals in United States may experience prolonged symptoms following SARS-CoV-2 infection,including cardiovascular abnormalities.1 Similarly,a 2021 retrospective cohort study in England suggest that the incidence of major adverse cardiovascular events(e.g.heart failure,myocardial infarction,ischemic stroke.展开更多
Cardiovascular disease remains a leading cause of morbidity and mortality,a fact that is commonly associated with co-morbidities such as clinical depression.While phase II cardiac rehabilitation is an established inte...Cardiovascular disease remains a leading cause of morbidity and mortality,a fact that is commonly associated with co-morbidities such as clinical depression.While phase II cardiac rehabilitation is an established intervention for those with cardiovascular disease,its effect on patients who also suffer from depression are under studied.Aim:To quantify Pre-and Post-cardiac rehabilitation questionnaire scores collected from a large patient data registry.For this investigation,27670 patients completed Patient Health Questionnaire-9 questionnaires both Pre-and Post-rehabilitation(averaging[28.08.7]phase II sessions).Findings reveal that questionnaire scores decreased by 40%–48%across all groups,a finding that was independent of assigned sex,race,and ethnicity.Moreover,when data were stratified for questionnaire scores that may indicate major and minor depressive disorder,phase II cardiac rehabilitation outcomes were lower by 61%and 49%respectively.While all groups exhibited lower questionnaire scores following cardiac rehabilitation participation,numerical differences at Preand Post-rehabilitation time points indicate that males and White patients have more favorable scores.This latter observation,while not confirmed currently,appears to be linked to referral rates to phase II cardiac rehabilitation,which remain poor for females,racial and ethnic minorities.展开更多
文摘More than 4 years has elapsed since the World Health Organization(WHO)officially announced the coronavirus disease 2019(COVID-19)as a pandemic outbreak in March 11,2020.Despite the ongoing investigations and political debates upon the origin,exacerbation,resurgence,andfinal control of COVID-19,medical and scientific consensus indicates that the now endemic COVID-19 virus is one of the worst public health crises in our lifetime.Almost every person on earth has been directly or indirectly impacted by the adverse effects of the highly contagious viral pathogen-SARS-CoV-2(severe acute respiratory syndrome coronavirus 2).Indeed,the population reach of the COVID-19 infection includes governmental response measures(e.g.,lockdowns and social distancing,mandates for masks and face coverings,vaccines,etc.)that have restricted entrenched societal routines,personal mobility,and lifestyles.Unfortunately,the host of health problems linked to this viral infection linger to this day,with selective groups of people experiencing a higher risk for untoward medical outcomes and/or elevated levels of vulnerability to the post-acute sequelae of COVID-19(i.e.long-COVID).For example,a 2021 study by Logue et al.provided initial evidence that 10%–30%of individuals in United States may experience prolonged symptoms following SARS-CoV-2 infection,including cardiovascular abnormalities.1 Similarly,a 2021 retrospective cohort study in England suggest that the incidence of major adverse cardiovascular events(e.g.heart failure,myocardial infarction,ischemic stroke.
文摘Cardiovascular disease remains a leading cause of morbidity and mortality,a fact that is commonly associated with co-morbidities such as clinical depression.While phase II cardiac rehabilitation is an established intervention for those with cardiovascular disease,its effect on patients who also suffer from depression are under studied.Aim:To quantify Pre-and Post-cardiac rehabilitation questionnaire scores collected from a large patient data registry.For this investigation,27670 patients completed Patient Health Questionnaire-9 questionnaires both Pre-and Post-rehabilitation(averaging[28.08.7]phase II sessions).Findings reveal that questionnaire scores decreased by 40%–48%across all groups,a finding that was independent of assigned sex,race,and ethnicity.Moreover,when data were stratified for questionnaire scores that may indicate major and minor depressive disorder,phase II cardiac rehabilitation outcomes were lower by 61%and 49%respectively.While all groups exhibited lower questionnaire scores following cardiac rehabilitation participation,numerical differences at Preand Post-rehabilitation time points indicate that males and White patients have more favorable scores.This latter observation,while not confirmed currently,appears to be linked to referral rates to phase II cardiac rehabilitation,which remain poor for females,racial and ethnic minorities.
